TipRanks compiles stocks that Wall Street’s top analysts agree are strong buys. These 24 stocks have the highest upsides, based on averages of the top analysts’ price targets. Analysts see 340% upside to Coherus Biosciences’ stock. This year’s stock market outlook remains uncertain even after a return to a bull market in the second quarter.
The economic outlook is uncertain, too. The bond market is signaling a recession because of an inverted yield curve, while a strong jobs market and rallying stock market are pointing to strength.
Michael Cuggino, the president and portfolio manager of the Permanent Portfolio Family of Funds, calls the current economic environment a tale of two sides. His firm’s allocation is built to withstand various economic conditions regardless of which scenario plays out. Others, like Gary Black, a managing partner at The Future Fund, think the stock market will continue to trend up, and they’re betting on companies set to benefit from mega-trends.
But if you’re not about picking sides, one way through this year’s uncertainty is by looking at what Wall Street analysts agrees on most. TipRanks, a fintech company that compiles and analyzes stock-market data, curates a list of the stocks most loved by top analysts.
Below is its latest compilation of US-listed stocks that are rated as “strong buy,” beginning with names with the highest potential upside. Each slide includes the average of 12-month price targets released in the last three months, and a percentage upside to that target from the current price. TipRanks designates four or five-star ratings to top analysts based on three main criteria:
An analyst’s average returns.Profits or losses on recommendations.The volume of corrections and transactions they make